In New York, the startup Mantis Biotech has presented an innovative platform for creating “digital twins” of humans, combining artificial intelligence and physical modeling to address the issue of a lack of medical data.
This is reported by Finway
Innovative Approach to Modeling the Human Body
The technology being developed by Mantis Biotech allows for the creation of accurate digital copies of the human body using medical imaging, biometric sensor data, and motion capture systems. This data is processed using artificial intelligence language models and physical simulations, enabling the modeling of anatomical and physiological processes in various scenarios.
The platform helps overcome one of the main limitations of modern medicine — the lack of quality and representative data for research, especially in cases of rare diseases or atypical clinical situations. The use of synthetic datasets generated by digital twins opens new opportunities for testing medical hypotheses, training robotic surgeons, and predicting risks for patients.
“Digital twins allow us to recreate scenarios that cannot be obtained from real data, particularly concerning rare medical conditions,” explains the startup’s founder, Georgia Wichal.
Applications in Sports and Pharmaceuticals
At this stage, the Mantis Biotech platform is already being used in professional sports, particularly in collaboration with NBA teams. Thanks to digital models, specialists analyze the physical dynamics of athletes, identify injury risks, and optimize training loads.
The company sees its next step as entering the pharmaceutical market and clinical research. The technology will enable modeling the body’s response to various treatment methods, accelerating the development of new drugs and improving the quality of medical experiments without involving a large number of real patients.
In January 2026, Mantis Biotech raised $7.4 million in seed funding led by Decibel VC with participation from Y Combinator and other investors. The funds are planned to be directed towards enhancing the technology, expanding the team, and launching the product in the global market.
